These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 11041269)

  • 1. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
    Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
    J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential changes of dopaminergic receptors in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle.
    Araki T; Tanji H; Kato H; Itoyama Y
    J Neurol Sci; 1998 Oct; 160(2):121-7. PubMed ID: 9849794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal changes of dopaminergic and glutamatergic receptors in 6-hydroxydopamine-treated rat brain.
    Araki T; Tanji H; Kato H; Imai Y; Mizugaki M; Itoyama Y
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):365-75. PubMed ID: 10974608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential changes of [H]forskolin, [H]cyclohexyladenosine and [H]PN200-110 binding sites in the brain of 6-hydroxydopamine-lesioned rats.
    Araki T; Tanji H; Kato H; Imai Y; Mizugaki M; Itoyama Y
    Acta Physiol Scand; 2000 May; 169(1):71-8. PubMed ID: 10759613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of second messenger systems in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle.
    Araki T; Tanji H; Kato H; Mizugaki M; Itoyama Y
    Eur J Pharm Sci; 1999 Aug; 8(4):261-7. PubMed ID: 10425376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-aminobutyric acidA and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle.
    Araki T; Matsubara M; Fujihara K; Kato H; Imai Y; Itoyama Y
    Neurol Res; 2002 Jan; 24(1):107-12. PubMed ID: 11783749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increases in [3H]FK-506 and [3H]L-N(G)-nitro-arginine binding in the rat brain after nigrostriatal dopaminergic denervation.
    Araki T; Tanji H; Fujihara K; Kato H; Itoyama Y
    Metab Brain Dis; 1999 Mar; 14(1):21-31. PubMed ID: 10348311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in dopamine D2 receptors and 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine uptake in the brain of 6-hydroxydopamine-lesioned rats.
    Ishida Y; Kawai K; Magata Y; Takeda R; Hashiguchi H; Abe H; Mukai T; Saji H
    Neurodegener Dis; 2004; 1(2-3):109-12. PubMed ID: 16908982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
    Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL
    J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered melatonin MT
    Kang NH; Carriere CH; Bahna SG; Niles LP
    Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):261-76. PubMed ID: 1833219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
    Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI
    Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time dependent changes in DA uptake sites, D1 and D2 receptor binding and mRNA after 6-OHDA lesions of the medial forebrain bundle in the rat brain.
    Narang N; Wamsley JK
    J Chem Neuroanat; 1995 Jul; 9(1):41-53. PubMed ID: 8527037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of striatal cholinergic receptors after lesioning of the substantia nigra.
    Sanvarinda Y; Phivthongngam L; Govitrapong P
    Neurochem Int; 1998 Aug; 33(2):187-93. PubMed ID: 9761463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic changes of striatal dopamine D2 receptor binding at later stages after unilateral lesions of the medial forebrain bundle in Parkinsonian rat models.
    Sun W; Sugiyama K; Asakawa T; Yamaguchi H; Akamine S; Ouchi Y; Magata Y; Namba H
    Neurosci Lett; 2011 Jun; 496(3):157-62. PubMed ID: 21514359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion.
    Xu ZC; Ling G; Sahr RN; Neal-Beliveau BS
    Brain Res; 2005 Mar; 1038(2):163-70. PubMed ID: 15757632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
    Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
    Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.
    Przedborski S; Levivier M; Jiang H; Ferreira M; Jackson-Lewis V; Donaldson D; Togasaki DM
    Neuroscience; 1995 Aug; 67(3):631-47. PubMed ID: 7675192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.